Search hospitals > Kentucky > Louisville
UofL Health Medical Center Northeast
Claim this profileLouisville, Kentucky 40245
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Non-Small Cell Lung Cancer
173 reported clinical trials
10 medical researchers
Summary
UofL Health Medical Center Northeast is a medical facility located in Louisville, Kentucky. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Cancer, Non-Small Cell Lung Cancer and other specialties. UofL Health Medical Center Northeast is involved with conducting 173 clinical trials across 355 conditions. There are 10 research doctors associated with this hospital, such as Richard L. Deming, Neal E. Dunlap, Rebecca Redman, MD, and Mohamed M. Hegazi.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage II
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Richard L. DemingMercy Medical Center - Des Moines6 years of reported clinical research
Expert in Breast Cancer
Expert in Cancer
178 reported clinical trials
242 drugs studied
Neal E. DunlapThe James Graham Brown Cancer Center at University of Louisville4 years of reported clinical research
Studies Squamous Cell Carcinoma
Studies Lung Cancer
19 reported clinical trials
45 drugs studied
Rebecca Redman, MDJames Graham Brown Cancer Center1 year of reported clinical research
Studies Squamous Cell Carcinoma
Studies Cancer
16 reported clinical trials
29 drugs studied
Mohamed M. HegaziThe James Graham Brown Cancer Center at University of Louisville8 years of reported clinical research
Studies Acute Myelogenous Leukemia
Studies Acute Myeloid Leukemia
10 reported clinical trials
33 drugs studied
Clinical Trials running at UofL Health Medical Center Northeast
Bladder Cancer
Lung Cancer
Skin Cancer
Prostate Cancer
Breast Cancer
Breast cancer
Kidney Cancer
Bladder Carcinoma
Cancer
Testicular cancer
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
Gemcitabine + Cisplatin
for Bladder Cancer
This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Recruiting1 award Phase 2
Immunotherapy + Radiation
for Bladder Cancer
This phase II trial tests the effect of giving pembrolizumab in combination with radiation therapy after chemotherapy in preventing surgery to remove the bladder in patients with muscle invasive bladder cancer. Standard of care therapy includes chemotherapy before surgery (neoadjuvant) to shrink or get rid of the tumor. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Photon beam radiation therapy is a type of radiation therapy that uses x-rays or gamma rays that come from a special machine called a linear accelerator. The radiation dose is delivered at the surface of the body and goes into the tumor and through the body. Giving pembrolizumab in combination with radiation therapy after neoadjuvant chemotherapy may help prevent surgical removal of the bladder in patients with muscle invasive bladder cancer.
Recruiting1 award Phase 22 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at UofL Health Medical Center Northeast?
UofL Health Medical Center Northeast is a medical facility located in Louisville, Kentucky. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Cancer, Non-Small Cell Lung Cancer and other specialties. UofL Health Medical Center Northeast is involved with conducting 173 clinical trials across 355 conditions. There are 10 research doctors associated with this hospital, such as Richard L. Deming, Neal E. Dunlap, Rebecca Redman, MD, and Mohamed M. Hegazi.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.